首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   6342篇
  免费   463篇
  国内免费   32篇
耳鼻咽喉   52篇
儿科学   158篇
妇产科学   102篇
基础医学   744篇
口腔科学   84篇
临床医学   841篇
内科学   1293篇
皮肤病学   113篇
神经病学   501篇
特种医学   284篇
外科学   1017篇
综合类   58篇
一般理论   3篇
预防医学   548篇
眼科学   87篇
药学   458篇
中国医学   7篇
肿瘤学   487篇
  2023年   61篇
  2022年   105篇
  2021年   331篇
  2020年   183篇
  2019年   245篇
  2018年   273篇
  2017年   197篇
  2016年   174篇
  2015年   262篇
  2014年   270篇
  2013年   384篇
  2012年   470篇
  2011年   503篇
  2010年   267篇
  2009年   200篇
  2008年   302篇
  2007年   304篇
  2006年   316篇
  2005年   230篇
  2004年   219篇
  2003年   188篇
  2002年   163篇
  2001年   91篇
  2000年   69篇
  1999年   71篇
  1998年   68篇
  1997年   67篇
  1996年   61篇
  1995年   60篇
  1994年   23篇
  1993年   39篇
  1992年   47篇
  1991年   47篇
  1990年   52篇
  1989年   46篇
  1988年   47篇
  1987年   42篇
  1986年   33篇
  1985年   44篇
  1984年   33篇
  1983年   20篇
  1982年   19篇
  1980年   13篇
  1979年   15篇
  1978年   16篇
  1973年   13篇
  1971年   13篇
  1970年   13篇
  1968年   15篇
  1966年   13篇
排序方式: 共有6837条查询结果,搜索用时 0 毫秒
81.
ObjectiveTo identify factors associated with patients’ overall rating of inpatient hospital care.ConclusionsOur results are novel in the Canadian population. Several questions for future research have been generated, in addition to opportunities for quality improvement within our own organization.  相似文献   
82.
83.
目的 研究不同平台压参数设置下,急性肺损伤(acute lung injury, ALI)家猪的跨肺压(transpulmonary pressure)等呼吸力学参数,明确平台压30cmH2O能否全面准确反应ARDS呼吸力学情况。方法 将6只健康家猪麻醉、进行外科手术后,按照以下不同实验状态进行机械通气: A组平台压<30cmH2O、B组平台压>30cmH2O伴腹内高压(intra-abdominal hypertension, IAH)。观察不同分组通气参数设置下,肺应力、平台压等呼吸力学标。结果呼吸力学: A组肺应力为(15.07±1.47)cmH2O高于 B组(10.92±1.28)cmH2O;B组胸壁弹性阻力与呼吸系统弹性阻力之比(Ecw/Ers)为(0.36±0.06)高于A组(0.24±0.05);B组肺顺应性(Cdyn)为(13.38±2.79)ml/cmH2O,明显高于A组(10.26±1.18)ml/cmH2O ;差异均有统计学意义(P<0.01)。B组胸壁顺应性(Ccw)为(43.12±8.00)ml/cmH2O,低于A组(63.28±36.71)ml/cmH2O,差异均有统计学意义(P<0.01)。结论 单纯以平台压30cmH2O作为机械通气的标准,不能准确地反映ARDS患者肺部的呼吸力学。腹内高压时,需要更高的平台压来改善氧合状况。肺应力和应变是真正反应ARDS肺呼吸力学的指标,将肺应力和应变理论引入临床,有利于为ARDS患者制定更加安全、合理的通气策略。  相似文献   
84.
85.
86.
87.
88.
A discrete cue associated with intravenous injections of cocaine acquires greater control over motivated behavior in some rats (‘sign-trackers'', STs) than others (‘goal-trackers'', GTs). It is not known, however, if such variation generalizes to cues associated with other drugs. We asked, therefore, whether a discrete cue (a light) associated with the intravenous administration of an opioid drug (the short-acting mu receptor agonist, remifentanil) acquires incentive motivational properties differently in STs and GTs, as indicated by tests of Pavlovian conditioned approach and conditioned reinforcement. Consistent with studies using cocaine, STs approached a classically conditioned opioid cue more readily than GTs, and in a test of conditioned reinforcement worked more avidly to get it. Interestingly, STs and GTs did not differ in the acquisition of a conditioned orienting response. In addition, the performance of conditioned approach behavior, but not conditioned orientation, was attenuated by pretreatment with the dopamine receptor antagonist, flupenthixol, into the core of the nucleus accumbens. Lastly, food and opioid cues engaged similar amygdalo–striatal–thalamic circuitry to a much greater extent in STs than GTs, as indicated by Fos expression. Taken together, these data demonstrate that, similar to food and cocaine cues: (1) a discrete opioid cue attains greater incentive motivational value in STs than GTs; (2) the attribution of incentive motivational properties to an opioid cue is dopamine dependent; and (3) an opioid cue engages the so-called ‘motive circuit'' only if it is imbued with incentive salience.  相似文献   
89.
90.

Purpose of the Review

Fish oil (FO) supplementation has historically been used by individuals suffering from cardiovascular disease and other inflammatory processes. However, a meta-analysis of several large randomized control trials (RCTs) suggested FO conferred no benefit in reducing cardiovascular risk. Skeptics surmised that the lack of benefit was related to FO dose or drug interactions; therefore, the widely accepted practice of FO consumption was brought into question.

Recent Findings

Thereafter, Serhan et al. identified specialized pro-resolving mediators (SPMs) to be one of the bioactive components and mechanisms of action of FO. SPMs are thought to enhance resolution of inflammation, as opposed to classic anti-inflammatory agents which inhibit inflammatory pathways. Numerous diseases, including persistent Inflammation, immunosuppression, and catabolic syndrome (PICS), are rooted in a burden of chronic inflammation. SPMs are gaining traction as potential therapeutic agents used to resolve inflammation in cardiovascular disorders, inflammatory bowel disease, sepsis, pancreatitis, and acute respiratory distress syndrome (ARDS).

Summary

This narrative reviews the history of FO and the various studies that made the health benefits of FO inconclusive, as well as an overview of SPMs and their use in specific disease states.
  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号